APEX HEALTHCARE BHD

KLSE (MYR): AHEALTH (7090)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

2.90

Today's Change

+0.01 (0.35%)

Day's Change

2.89 - 2.90

Trading Volume

5,700

Overview

Market Cap

1,383 Million

NOSH

477 Million

Avg Volume (4 weeks)

109,050

4 Weeks Range

2.80 - 3.07

4 Weeks Price Volatility (%)

37.04%

52 Weeks Range

2.38 - 3.20

52 Weeks Price Volatility (%)

63.41%

Previous Close

2.90

Open

2.90

Bid

2.90 x 200

Ask

2.94 x 1,700

Day's Range

2.89 - 2.90

Trading Volume

5,700

Financial Highlight

Latest Quarter | Ann. Date

31-Mar-2022 [#1] | 18-May-2022

Next QR | Est. Ann. Date

30-Jun-2022 | 19-Aug-2022

T4Q P/E | EY

21.85 | 4.58%

T4Q DY | Payout %

3.94% | 86.03%

T4Q NAPS | P/NAPS

1.09 | 2.66

T4Q NP Margin | ROE

7.85% | 12.15%

Market Buzz
Company Profile

Sector: HEALTH CARE

Sector: HEALTH CARE

Subsector: PHARMACEUTICALS

Subsector: PHARMACEUTICALS

Description:

Apex Healthcare Bhd is a public limited liability company, incorporated and domiciled in Malaysia. The Company is an investment holding company for a group of companies engaged in the business of manufacturing, marketing, distributing and retailing of pharmaceuticals, diagnostics, orthopaedics and consumer healthcare products with direct operations in Malaysia, Singapore and Vietnam. Its operations are organized into three segments: Manufacturing and Marketing, Wholesale and Distribution, and Corporate.

Discussions
5 people like this. Showing 50 of 423 comments

NPRA1985

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approva...

2020-12-03 00:37

NPRA1985

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-...

2020-12-03 00:38

NPRA1985

Promise of Covid vaccines is ‘phenomenal’, WHO says

https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of...

2020-12-03 22:25

NPRA1985

Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets

https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162...

2020-12-03 22:47

NPRA1985

DUBAI: Bahrain said on Friday it has granted emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.

The kingdom had also approved Sinopharm’s COVID-19 vaccine in November for use by frontline workers.

https://www.arabnews.com/node/1772516/middle-east

2020-12-05 01:33

NPRA1985

South Korea reaches deal to buy AstraZeneca's Covid-19 vaccine candidate

https://www.straitstimes.com/asia/east-asia/south-korea-reaches-deal-t...

2020-12-05 01:46

NPRA1985

500 million vaccine doses in Q1 2021 closer to reality, says WHO

https://www.freemalaysiatoday.com/category/world/2020/12/05/500-millio...

2020-12-05 14:34

NPRA1985

UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-u...

2020-12-09 15:12

NPRA1985

United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirate...

2020-12-09 22:25

NPRA1985

Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the...

2020-12-10 23:55

NPRA1985

FDA intends to 'proceed towards an authorization' of Covid-19 vaccine, official says, as cases soar

(CNN)The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.

The statement comes a day after an FDA panel recommended the agency grant an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine.Other key steps remain, but if those hurdles are cleared, the first vaccinations in the US could happen early next week, HHS Secretary Alex Azar told ABC's George Stephanopoulos.

"The FDA informed Pfizer that they do intend to proceed toward an authorization for their vaccine," Azar told ABC Friday morning.

https://edition.cnn.com/2020/12/11/health/us-coronavirus-friday/index....

2020-12-12 02:26

NPRA1985

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccin...

2020-12-12 15:04

NPRA1985

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expe...

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-...

2020-12-12 18:05

FT1981

this counter not active?

2021-01-07 11:19

NPRA1985

Post removed.Why?

2021-02-03 22:03

KaiHong

this is a stable stock

2021-02-15 15:00

Aa01182

Sleeping giant

2021-03-11 23:02

jomvalueinvest2

Vaccine counter wave coming ? Kanger seems like more hot now

2021-05-18 14:39

Mr.Sm Invest123

Apex Healthcare Bhd
Target price: RM3.33 BUY


AMINVESTMENT BANK RESEARCH (MAY 24): The drag from associated company Straits Apex Sdn Bhd (SA) is expected to ease in the coming quarters. Major customer Smith and Nephew Sales Sdn Bhd, which contributes to about 62% of SA sales, performed the bulk of 1QFY21’s transactions in 4QFY20. Pandemic uncertainty has also led it to delay the bulk of its remaining orders to 2HFY21. Currently, order levels are similar to last year’s.

However, poor utilisation rates at SPP NOVO are expected to keep manufacturing segment margins depressed; therefore, the group is deferring expansion plans until pharmaceutical demand returns.

Meanwhile, rising freight and raw material costs are likely to compress margins in the coming quarters. While ASPs for group brand products remain unchanged, they may rise in the coming quarters. External products have already seen a 6% increase in ASP.

With the Ministry of Health’s (MoH) expenses tied up by the pandemic’s resurgence, the group believes government tenders are hard to come by at the moment. We expect this to normalise in FY22F, as the bulk of the MoH’s mass vaccinations will have already been completed by then. Going forward, we remain positive on Apex’s future prospects as a recovery play.

2021-06-07 18:49

wallstreetrookie

A Guide to Investing in Healthcare Companies

Low tier: IHH, TopGlove, Supermaxm Pharmaniaga
High tier: YSPSAH, Apex Healthcare, Duopharma

2021-06-10 15:03

wallstreetrookie

Though the company only gets a small slice of the meat within the pharmaceutical business, manufacturing generic medication remains profitable and attractive for defensive investments.

2021-06-22 04:55

wallstreetrookie

I like this company

2021-06-24 06:20

wallstreetrookie

Political instability always presents the best opportunities to buy the dips. When everyone's attention is grabbed by glove companies, it is the perfect chance to buy in alternative healthcare and pharmaceutical companies. And for what's worth, Apex Healthcare is a well-managed company

2021-06-24 13:02

wallstreetrookie

If you want defensive stocks, this is the one

2021-06-24 23:32

CynicalCyan

21 years ago, AHEALTH was first listed on the Second Board with around 100 mil in market capitalisation.
21 years later, AHEALTH became one of the most consistent profitable companies on Bursa Main Market with about 1 bil in market capitalisation.

Hats off to such an outstanding Malaysian company. May the next 21 years be even better.

2021-06-26 22:29

telurgoreng

Apex and YSP are both good defensive counters. But YSP seems to be the better value given the price and dividend yield.

2021-07-15 16:19

Hafid

PROBLEM IS NO GROWTH

2021-07-15 16:21

telurgoreng

They are investing a lot into production, machine and factories hence less money to be given out as dividends. The share is non-speculative due to most of the holdings are held by the directors and owners. Hence it is very hard to goreng shares like this. These are the "Tanker" shares, they can easily tank recession and outlast the smallcap counters.

If you prefer gambling and speculative shares, you're better off buying penny stocks as those have almost 0 returns and price swing wildly due to rumours and speculation. Depending on which type of investor you are, some people prefer insurance and banking, some people prefer healthcare, some prefer energy, some people just follow the wind and hype according to what come out in the newspaper during the moment.. Price movement may be boring, but this is for slow and steady, keep for long term or retirement kind like bank shares.

My take is, the share hasn't seen any bonus in over 10 years. They have grown steadily in terms of asset. Hence, I foresee they may issue bonus eventually when the industry recovers and we are in better financial situation. It's not like they're having debt problems or not-profitable. The share price is just boring cause most of the shareholding held by the owners and directors, so there is not enough public shares for operators to goreng.

2021-07-15 22:47

Nepo

Apex declared bonus issues in Year 2018

2021-07-16 06:08

Hafid

I rather wait until below rm1.40

2021-07-17 05:21

Bgt 9963

Post removed.Why?

2021-07-17 09:04

trum

Steady

2021-08-21 10:20

wallstreetrookie

Company has been forgotten

2021-08-27 10:50

wallstreetrookie

Read @telurgoreng's post. It is good research and I've taken note of it

2021-08-27 10:50

wallstreetrookie

Another stock to watch next week

2021-08-29 23:31

investortrader88

BURSA MALAYSIA TRADE STATISTICS - 27 AUG 2021

Participation / Status / Nett RM ( M )

Institutions Nett sellers - 239.8

Retail Nett sellers - 16.9

Foreign Nett buyers + 256.7



Source: theSundaily - Business

2021-08-30 19:21

investortrader88

Top 25 shareholders own 84.79% of Apex Healthcare Berhad's

Apex Pharmacy Holdings Sdn. Bhd.
39.99%

Washington H. Soul Pattinson and Company Limited
29.81%

Md Md Dewal
1.68%

Public Mutual Berhad
1.6%

Lim Teh Realty Sdn Berhad
1.37%

Kirk Kee
1.08%

Yoon Yee Liew
0.99%

Xepa Holdings Sendirian Berhad
0.86%

Yan Meng Tan
0.84%

DBS Group Holdings Limited, Asset Management Arm
0.8%

Apex Holdings (Pte) Ltd.
0.54%

Employees Provident Fund of Malaysia
0.54%

Heng Koon Chan
0.52%

Choon Neo Teoh
0.5%

Singam Kumarasamy
0.46%

FMR LLC
0.41%

Lee Hee Yeo
0.39%

Manulife Asset Management Services Berhad
0.37%

Capital Dynamics Asset Management Sdn Bhd
0.36%

Siew Heong Oh
0.34%

Yee Hui Wong
0.34%

Jin Thai Tan
0.27%

Ding Susy
0.26%

Leong Kuen
0.25%

Kenanga Investors Berhad
0.22%

2021-08-30 22:32

wallstreetrookie

best alternative healthcare

2021-09-01 15:13

Nepo

3 Sept 2021

Apex Healthcare Bhd said it has inked an agreement with Innova Bio-Medical Pte Ltd to supply the Sinopharm Covid-19 vaccine to private healthcare practitioners in Singapore. Innova is part of the Innova Medical Group, a global company specializing in innovative screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke, and virus detection focused on infectious diseases. Under the deal, Innova will supply the Chinese-made vaccine to Apex’s wholly-owned unit in Singapore, Apex Pharma Marketing Pte Ltd, for onward sale and distribution to hospitals and private clinics within the city state, said Apex Healthcare.

2021-09-04 11:34

Nepo

(吉隆坡3日讯)Apex保健(AHEALTH,7090,主板消费股)在新加坡的独资子公司 ——Apex Pharma Marketing(APM)获得国药(Sinopharm)疫苗供应合约。

Apex保健周五发文告指出,APM已在8月31日,和Innova生物医学公司签署供应协议,供应国药疫苗予新加坡私人诊所和医院。

该公司补充,第一批疫苗供应量为3万1600剂,会在9月中到货。

周五闭市,Apex保健收报3.01令吉,无起落,有1万8200股易手。

2021-09-04 11:36

wallstreetrookie

@Nepo that is bad news

2021-09-13 09:59

wallstreetrookie

One of the less well-known healthcare stocks. Buying the dip

2021-09-30 14:59

goody99

people expected AHEALTH would get the benefit when the pandemic started. Unfortunately its revenue and profit have been so-so for 6 quarters. Disappointed. it will not surprise me if its share price is going back to the price before the pandemic.

2021-10-09 16:54

airfan99

Wait for it to drop to RM1.80

2021-11-18 09:19

jomvalueinvest2

current share price still steady

2021-12-13 10:12

Trade in Peace

长期空头,而且季均线以下。手上有的只能做短线,近期跌破sma5出场
https://www.youtube.com/watch?v=voWmOcBQyb4

2022-01-03 04:03

jomvalueinvest2

When you think it drops. It goes up.

3 weeks ago

Post a Comment